Incidence and treatment of malignant tumors of the genitourinary tract in renal transplant recipients

International Braz J Urol : Official Journal of the Brazilian Society of Urology
Juan Manuel Ochoa-LópezRicardo Alonso Castillejos-Molina

Abstract

To provide data of the incidence and management of common urological malignancies in renal transplant recipients. We conducted a retrospective analysis of a prospective database from August 1967 to August 2015. A descriptive analysis of the sample was performed. Among 1256 consecutive RTR a total of 88 patients developed malignancies (7%). There were 18 genitourinary tumors in the 16 patients (20.45% of all malignant neoplasms), incidence of 1.27%. The most common neoplasm encounter was renal cancer (38.8%), followed by urothelial carcinoma (33.3%). Median follow up of transplantation was 197 months (R, 36-336). Mean time from RT to cancer diagnosis 89±70 months (R, 12-276). CsA and AZA was the most common immunosuppression regimen in 68.75%. Mean follow-up after diagnosis was 103±72 months (R 10-215). Recurrence free survival rate of 100%. Overall survival of 89.5% of the sample; there were two non-related cancer deaths during follow up. The incidence of neoplasms in RTR was lower than in other series, with favorable functional and oncologic results after treatment. This suggests that actions to reduce the risk of these malignancies as well as a strict follow-up are mandatory for an early detection and treatment.

References

Nov 7, 2002·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·J William CharboneauDonald E Engen
Feb 10, 2004·The Journal of Urology·Viraj A MasterPeter R Carroll
May 19, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Bertram L KasiskeChangchun Wang
Jun 21, 2005·Transplantation Proceedings·R DillerH-U Spiegel
Aug 24, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Caroline DeanStephen Holt
Oct 8, 2005·Transplantation·Nicolas A Muruve, Daniel A Shoskes
Oct 28, 2005·Transplantation·Joseph F BuellE Steve Woodle
Oct 31, 2006·Urology·Gregory W HrubyJaime Landman
May 16, 2009·International Journal of Cancer. Journal International Du Cancer·Claire M Vajdic, Marina T van Leeuwen
Jul 11, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·John H StewartMargaret R E McCredie
Oct 28, 2009·Transplantation Proceedings·X TillouJ Petit
Dec 21, 2010·The Journal of Urology·Sebastian MelchiorKurt Dreikorn
Feb 22, 2011·Transplantation Proceedings·N MaglakelidzeA Chkhotua
Feb 22, 2011·Transplantation Proceedings·G Karam, M Giessing
Mar 5, 2011·International Urology and Nephrology·Jared Cox, Janet L Colli
Nov 3, 2011·JAMA : the Journal of the American Medical Association·Eric A EngelsMonica Lin
Jul 27, 2012·The New England Journal of Medicine·Sylvie EuvrardUNKNOWN TUMORAPA Study Group
Feb 11, 2014·Transplantation Proceedings·V HeviaF J Burgos
Aug 19, 2015·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Quentin-Côme Le ClercGeorgess Karam

❮ Previous
Next ❯

Citations

Dec 7, 2018·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Michael S Floyd, Altaf Q Khattak
Dec 17, 2021·Current Urology Reports·Cristian Axel Hernández-GaytánAna María Autrán-Gómez

❮ Previous
Next ❯

Methods Mentioned

BETA
RAP
circumcision

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.